- Home
- VZLA vs QDEL Comparison
VZLA vs QDEL Comparison
Compare VZLA & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VZLA | QDEL |
|---|---|---|
| Founded | 2017 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | VZLA | QDEL |
|---|---|---|
| Price | $3.76 | $14.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $7.00 | ★ $28.25 |
| AVG Volume (30 Days) | ★ 5.1M | 1.5M |
| Earning Date | 12-12-2025 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.88 | $9.92 |
| 52 Week High | $7.19 | $35.58 |
Technical Indicators
Market Signals| Indicator | VZLA | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 42.44 |
| Support Level | $3.21 | $11.01 |
| Resistance Level | $3.95 | $18.15 |
| Average True Range (ATR) | 0.15 | 1.13 |
| MACD | 0.05 | -0.31 |
| Stochastic Oscillator | 79.26 | 43.44 |
Price Performance
Historical ComparisonAbout VZLA Vizsla Silver Corp.
Vizsla Silver Corp is the exploration of mineral properties. The company currently conducts substantially all its operations in Canada and Mexico in one reportable segment. The company has one reportable segment, mainly mineral exploration, evaluation and development. Its project includes Panuco Project.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.